Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume $7.05 -0.05 (-0.70%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$6.98 -0.08 (-1.06%) As of 08/15/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyra Therapeutics Short Interest DataLyra Therapeutics (LYRA) has a short interest of 45,600 shares, representing 2.95% of the float (the number of shares available for trading by the public). This marks a -8.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 30,703 shares to cover all short positions.Current Short Interest45,600 sharesPrevious Short Interest49,900 sharesChange Vs. Previous Month-8.62%Dollar Volume Sold Short$305.52 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares1,645,000 sharesShort Percent of Float2.95%Today's Trading Volume10,621 sharesAverage Trading Volume30,703 sharesToday's Volume Vs. Average35% Short Selling Lyra Therapeutics? Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYRA Short Interest Over TimeLYRA Days to Cover Over TimeLYRA Percentage of Float Shorted Over Time Lyra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202545,600 shares $305.52 thousand -8.6%2.9%0.1 $6.70 7/15/202549,900 shares $423.15 thousand -59.7%N/A0.1 $8.48 6/30/2025123,900 shares $1.11 million +8.9%7.7%0.2 $8.96 6/15/2025113,800 shares $1.29 million +37.9%8.6%0.2 $11.34 5/31/202582,500 shares $386.10 thousand -43.7%7.4%0.1 $4.68 5/15/2025146,600 shares $16.54 thousand -94.6%13.1%2.3 $0.11 4/30/20252,700,000 shares $320.76 thousand +21.6%N/A1.5 $0.12 4/15/20252,220,000 shares $204.68 thousand -7.9%3.6%1.9 $0.09 3/31/20252,410,000 shares $304.38 thousand +0.4%3.9%2.2 $0.13 3/15/20252,400,000 shares $412.80 thousand +27.7%3.8%2 $0.17 Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,880,000 shares $402.32 thousand -13.4%3.0%1.5 $0.21 2/15/20252,170,000 shares $451.79 thousand +1.4%3.5%1.5 $0.21 1/31/20252,140,000 shares $391.19 thousand +0.5%N/A1.2 $0.18 1/15/20252,130,000 shares $402.57 thousand +1.4%N/A1.1 $0.19 12/31/20242,100,000 shares $433.44 thousand +14.1%N/A1.1 $0.21 12/15/20241,840,000 shares $335.98 thousand -16.4%N/A1.1 $0.18 11/30/20242,200,000 shares $455.40 thousand -7.6%N/A1.4 $0.21 11/15/20242,380,000 shares $404.60 thousand +16.7%N/A1.6 $0.17 10/31/20242,040,000 shares $560.80 thousand -4.7%N/A2.1 $0.27 10/15/20242,140,000 shares $488.78 thousand -24.9%N/A2.2 $0.23 9/30/20242,850,000 shares $732.45 thousand -9.2%N/A3.2 $0.26 9/15/20243,140,000 shares $879.20 thousand +6.1%N/A2.7 $0.28 8/31/20242,960,000 shares $952.23 thousand -28.7%N/A2.3 $0.32 8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29 7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33 7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31 6/30/20241,990,000 shares $550.63 thousand +28.4%N/A0.5 $0.28 6/15/20241,550,000 shares $457.56 thousand +71.8%N/A0.4 $0.30 5/31/2024902,200 shares $295.92 thousand +49.6%N/A0.3 $0.33 5/15/2024603,000 shares $214.55 thousand +45.7%N/A0.2 $0.36 4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16 4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27 3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22 3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93 2/29/2024160,200 shares $842.65 thousand -13.6%N/A0.6 $5.26 2/15/2024185,400 shares $927 thousand +43.5%N/A0.8 $5.00 1/31/2024129,200 shares $587.86 thousand -5.6%N/A0.6 $4.55 1/15/2024136,900 shares $736.52 thousand -22.6%N/A0.6 $5.38 12/31/2023176,800 shares $926.43 thousand +2.4%N/A0.9 $5.24 12/15/2023172,600 shares $802.59 thousand -24.4%N/A0.7 $4.65This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 11/30/2023228,300 shares $755.67 thousand -13.9%N/A0.6 $3.31 11/15/2023265,200 shares $766.43 thousand -17.3%N/A0.7 $2.89 10/31/2023320,600 shares $952.18 thousand +43.2%N/A0.9 $2.97 10/15/2023223,900 shares $801.56 thousand -38.2%N/A0.6 $3.58 9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91 9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35 8/31/202355,300 shares $192.44 thousand -19.5%N/A0.3 $3.48 8/15/202368,700 shares $245.95 thousand -67.0%N/A0.4 $3.58 7/31/2023208,100 shares $670.08 thousand -62.3%N/A1.1 $3.22 7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06 6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11 6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99 5/31/2023285,500 shares $733.74 thousand +1,513.0%N/A3.7 $2.57 5/15/202317,700 shares $46.20 thousand -31.4%N/A0.5 $2.61 4/30/202325,800 shares $61.92 thousand +27.1%N/A0.7 $2.40 4/15/202320,300 shares $48.52 thousand +178.1%N/A0.6 $2.39 3/31/20237,300 shares $14.67 thousand -29.1%N/A0.2 $2.01 3/15/202310,300 shares $21.01 thousand -32.2%N/A0.3 $2.04 2/28/202315,200 shares $36.18 thousand +22.6%N/A0.5 $2.38 2/15/202312,400 shares $30.26 thousand +21.6%N/A0.4 $2.44 1/31/202310,200 shares $29.07 thousand -21.5%N/A0.3 $2.85 1/15/202313,000 shares $36.01 thousand -29.7%N/A0.2 $2.77 12/30/202218,500 shares $58.09 thousand +44.5%N/A0.3 $3.14 12/15/202212,800 shares $34.94 thousand -41.6%N/A0.2 $2.73 11/30/202221,900 shares $76.87 thousand +0.5%N/A0.3 $3.51 11/15/202221,800 shares $85.02 thousand No ChangeN/A0.3 $3.90 10/31/202221,800 shares $102.24 thousand -27.6%N/A0.3 $4.69 10/15/202230,100 shares $144.48 thousand -16.4%N/A0.9 $4.80 9/30/202236,000 shares $180.36 thousand -45.4%N/A1 $5.01 9/15/202265,900 shares $392.76 thousand -25.5%N/A1.6 $5.96 8/31/202288,400 shares $511.84 thousand -18.8%N/A1.4 $5.79 8/15/2022108,800 shares $683.26 thousand -22.6%N/A1.6 $6.28 7/31/2022140,600 shares $912.49 thousand -44.2%N/A1.9 $6.49 7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69 6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65 6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02 5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35 5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88 4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65 4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51 3/31/202277,200 shares $310.34 thousand +19.0%0.9%0.5 $4.02 3/15/202264,900 shares $262.85 thousand -44.8%0.7%1.5 $4.05 2/28/2022117,500 shares $572.23 thousand +36.3%1.2%2.4 $4.87 2/15/202286,200 shares $387.90 thousand +9.1%0.9%1.6 $4.50 1/31/202279,000 shares $323.11 thousand +5.6%0.8%1.3 $4.09 1/15/202274,800 shares $295.46 thousand +4.0%0.8%1.2 $3.95 12/31/202171,900 shares $313.48 thousand -5.8%0.8%1.2 $4.36 12/15/202176,300 shares $334.19 thousand -1.0%0.8%1.4 $4.38 11/30/202177,100 shares $431.76 thousand +2.5%0.8%1.4 $5.60 11/15/202175,200 shares $539.94 thousand -51.4%0.9%1.5 $7.18This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30 10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85 9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12 9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28 8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14 8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94 7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44 7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45 6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03 6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17 5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18 5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46 4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18 4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89 3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17 3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98 2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00 2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19 1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68 1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96 LYRA Short Interest - Frequently Asked Questions What is Lyra Therapeutics' current short interest? Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 45,600 shares of LYRA short. 2.95% of Lyra Therapeutics' shares are currently sold short. Learn More on Lyra Therapeutics' current short interest. What is a good short interest percentage for Lyra Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.95% of Lyra Therapeutics' floating shares are currently sold short. Is Lyra Therapeutics' short interest increasing or decreasing? Lyra Therapeutics saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 45,600 shares, a decline of 8.6% from the previous total of 49,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lyra Therapeutics' short interest compare to its competitors? 2.95% of Lyra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: Nephros Inc. (0.05%), Modular Medical, Inc. (0.33%), NeuroOne Medical Technologies Corporation (0.34%), Precision Optics Corp. (1.19%), CollPlant Biotechnologies Ltd. Sponsored ADR (1.09%), electroCore, Inc. (7.83%), Envoy Medical, Inc. (0.90%), Femasys Inc. (1.41%), Vivos Therapeutics, Inc. (7.89%), DarioHealth Corp. (7.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Lyra Therapeutics stock? Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyra Therapeutics? A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further. How often is Lyra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Nephros Short Interest Data Modular Medical Short Interest Data NeuroOne Medical Technologies Short Interest Data Precision Optics Short Interest Data CollPlant Biotechnologies Short Interest Data electroCore Short Interest Data Envoy Medical Short Interest Data Femasys Short Interest Data Vivos Therapeutics Short Interest Data DarioHealth Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYRA) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access